Výsledky vyhledávání

Akademický článek

Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study.

Autor: Petrova NV; Research Institute of General Pathology and Pathophysiology, Moscow, Russia. nataliyaapetrova89@gmail.com.; LLC 'MATERIA MEDICA HOLDING', Moscow, Russia. nataliyaapetrova89@gmail.com., Emelyanova AG; Research Institute of General Pathology and Pathophysiology, Moscow, Russia.; LLC 'MATERIA MEDICA HOLDING', Moscow, Russia., Tarasov SA; Research Institute of General Pathology and Pathophysiology, Moscow, Russia.; LLC 'MATERIA MEDICA HOLDING', Moscow, Russia., Aparin PG; LLC 'GRITVAK', Moscow, Russia.; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia., Ledov VA; LLC 'GRITVAK', Moscow, Russia.; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2023 Sep; Vol. 175 (5), pp. 649-652. Date of Electronic Publication: 2023 Oct 20.

Zobrazit plný text záznamu

Akademický článek

A Pentavalent Shigella flexneri LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal Models.

Autor: Ledov VA; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, 115478 Moscow, Russia.; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia., Golovina ME; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, 115478 Moscow, Russia.; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia., Alkhazova BI; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia.; Laboratory of Preparative Biochemistry, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, 115478 Moscow, Russia., Lvov VL; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia.; Laboratory of Preparative Biochemistry, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, 115478 Moscow, Russia., Kovalchuk AL; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, 115478 Moscow, Russia., Aparin PG; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, 115478 Moscow, Russia.; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia.

Publikováno v: Vaccines [Vaccines (Basel)] 2023 Feb 03; Vol. 11 (2). Date of Electronic Publication: 2023 Feb 03.

Zobrazit plný text záznamu

Akademický článek

High-Level Production of Soluble Cross-Reacting Material 197 in Escherichia coli Cytoplasm Due to Fine Tuning of the Target Gene's mRNA Structure.

Autor: Khodak YA; Federal State Institution, Federal Research Centre 'Fundamentals of Biotechnology', The Russian Academy of Sciences, 119071 Moscow, Russia., Ryazanova AY; Federal State Institution, Federal Research Centre 'Fundamentals of Biotechnology', The Russian Academy of Sciences, 119071 Moscow, Russia., Vorobiev II; Federal State Institution, Federal Research Centre 'Fundamentals of Biotechnology', The Russian Academy of Sciences, 119071 Moscow, Russia., Kovalchuk AL; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia., Ovechko NN; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia., Aparin PG; National Research Center, Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia.; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia.

Publikováno v: Biotech (Basel (Switzerland)) [BioTech (Basel)] 2023 Jan 11; Vol. 12 (1). Date of Electronic Publication: 2023 Jan 11.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4.

Autor: Dyatlov IA; State Research Center for Applied Microbiology and Biotechnology, Rospotrebnadzor, 142279 Obolensk, Moscow Region, Russia., Svetoch EA; State Research Center for Applied Microbiology and Biotechnology, Rospotrebnadzor, 142279 Obolensk, Moscow Region, Russia., Mironenko AA; National Research Center Institute of Immunology Federal Medical-Biology Agency (FMBA of Russia), 115522 Moscow, Russia., Eruslanov BV; State Research Center for Applied Microbiology and Biotechnology, Rospotrebnadzor, 142279 Obolensk, Moscow Region, Russia., Firstova VV; State Research Center for Applied Microbiology and Biotechnology, Rospotrebnadzor, 142279 Obolensk, Moscow Region, Russia., Fursova NK; State Research Center for Applied Microbiology and Biotechnology, Rospotrebnadzor, 142279 Obolensk, Moscow Region, Russia., Kovalchuk AL; National Research Center Institute of Immunology Federal Medical-Biology Agency (FMBA of Russia), 115522 Moscow, Russia., Lvov VL; National Research Center Institute of Immunology Federal Medical-Biology Agency (FMBA of Russia), 115522 Moscow, Russia.; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia., Aparin PG; National Research Center Institute of Immunology Federal Medical-Biology Agency (FMBA of Russia), 115522 Moscow, Russia.; ATVD-TEAM Co., Ltd., 115522 Moscow, Russia.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Nov 01; Vol. 10 (11). Date of Electronic Publication: 2022 Nov 01.

Zobrazit plný text záznamu

Akademický článek

Various Adjuvants Effect on Immunogenicity of Puumala Virus Vaccine.

Autor: Kurashova SS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia., Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.; Institute for Translatonal Medicine and Bionechnology, Sechenov First Moscow State Medical University, Moscow, Russia., Dzagurova TK; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia., Egorova MS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia., Balovneva MV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia., Nikitin NA; Department of Virology, Lomonosov Moscow State University, Moscow, Russia., Evtushenko EA; Department of Virology, Lomonosov Moscow State University, Moscow, Russia., Karpova OV; Department of Virology, Lomonosov Moscow State University, Moscow, Russia., Markina AA; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia., Aparin PG; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia., Tkachenko PE; Department of Internal Medicine Propaedeutics, Sechenov First Moscow State Medical University, Moscow, Russia., L Vov VL; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia., Tkachenko EA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2020 Oct 26; Vol. 10, pp. 545371. Date of Electronic Publication: 2020 Oct 26 (Print Publication: 2020).

Zobrazit plný text záznamu

Akademický článek

Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Autor: Ledov VA; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, Moscow 115478, Russia., Golovina ME; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, Moscow 115478, Russia., Markina AA; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, Moscow 115478, Russia., Knirel YA; N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47, Leninsky Prospect, Moscow 117913, Russia., L'vov VL; Laboratory of Preparative Biochemistry, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, Moscow 115478, Russia., Kovalchuk AL; The Virology and Cellular Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20852, United States., Aparin PG; Laboratory of Carbohydrate Vaccines, National Research Center-Institute of Immunology, Federal Medical Biological Agency of Russia, 24, Kashirskoe Shosse, Moscow 115478, Russia. Electronic address: pg.aparin@nrcii.ru.

Publikováno v: Vaccine [Vaccine] 2019 Feb 14; Vol. 37 (8), pp. 1062-1072. Date of Electronic Publication: 2019 Jan 19.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání